Yield Theory

Robert Bresnahan · PFE

Robert Bresnahan's PFE trades

Every Pfizer Inc. transaction Robert Bresnahan reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
3
Buys / sells
2 / 1
Disclosed range
$45K – $150K
Last filed
2025-05-31

PFE transactions reported by Robert Bresnahan

3 of 3 rows
TypeOwner
Pfizer, Inc. Common Stock
PFE
PurchaseSelf$15,001 - $50,0002025-05-31
#20030433
Pfizer, Inc. Common Stock
PFE
SaleSelf$15,001 - $50,0002025-04-28
#20030238
Pfizer, Inc. Common Stock
PFE
PurchaseSelf$15,001 - $50,0002025-03-27
#20029034

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Robert Bresnahan and PFE — questions

Did Robert Bresnahan buy or sell PFE?

House Clerk filings for 2025 and 2026 show 2 purchases and 1 sale of Pfizer Inc. (PFE) reported by Robert Bresnahan, between 2025-02-25 and 2025-05-15. Reported owner: Self.

How much PFE did Robert Bresnahan trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $45K – $150K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last PFE filing by Robert Bresnahan?

The most recent periodic transaction report containing a PFE row was filed on 2025-05-31. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Pfizer Inc.. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Robert Bresnahan PFE disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included